Actively Recruiting
InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
Led by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Updated on 2024-11-21
250
Participants Needed
5
Research Sites
347 weeks
Total Duration
On this page
Sponsors
I
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Lead Sponsor
E
ERA PERMED
Collaborating Sponsor
AI-Summary
What this Trial Is About
Multicentric, exploratory, non-pharmacologic, retrospective/prospective, translational study aiming to identify the molecular, cellular and psychological-sociological variables predictive of response to chemotherapy in gastric cancer patients.
CONDITIONS
Official Title
InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with diagnosis of histologically confirmed, potentially resectable adenocarcinoma of the stomach or gastric-esophageal junction treated with standard chemotherapy regimens (5-Fluoro-Uracil or Capecitabine + Oxaliplatin +/- Docetaxel)
- Participants willing and able to give informed consent or with substitutive consent by the investigator for unreachable patients
- Male or female aged over 18 years
- Availability of tissue samples and clinical-pathological data for retrospective cohort
You will not qualify if you...
- Age under 18 years
- Early gastric cancer and T2 stage if no lymph node involvement
- Linitis plastica
- Positive peritoneal cytology or peritoneal involvement
- Distant metastases
- Patient refusal to participate
- Patient refusal to allow use of their samples for research
- Withdrawal from treatment due to co-morbidities or non-compliance
- Underlying conditions making biological sampling unsafe or unusable
- Mental illness impairing ability to provide accurate information or follow recommendations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Centre Hospitalier Regional et Universitaire (CHRU)
Brest, France, 29200
Not Yet Recruiting
2
INSERM, Faculty of Medicine (UMR1078)
Brest, France, 29200
Active, Not Recruiting
3
1st Department of Propaedeutic Surgery, National & Kapodistrian University of Athens (NKUA)
Athens, Greece, 11527
Not Yet Recruiting
4
IRST IRCCS UO Oncologia
Meldola, Italy, 47014
Actively Recruiting
5
AUSL Romagna, UO Oncologia
Ravenna, Italy, 48121
Active, Not Recruiting
Research Team
C
Chiara Molinari
CONTACT
C
Chiara Zingaretti
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here